Grant: Alliance Grants
Université Laval
$50,000.00
Live viral spectroscopy for rapid Covid-19 detection applied directly to clinical biofluids without sample processing_x000d_ _x000d_
EF 2020-21
Résumé
We propose a new partnership to advance the core technology for an innovative approach to rapid detection of COVID-19 called "live virus spectroscopy". The initiative brings together experts in virology, microfluidics, mechanical engineering, bioinformatics, and COVID diagnostics with world-leaders in spectroscopic instrument manufactures, Bruker, to advance and rapidly commercialize a new COVID-19 test method. The platform is based on a new patent pending microfluidic technology from Greener and Bégin-Drolet that will automatically meter and concentrate analytes, before obtaining high quality vibrational spectra independently from up to 20 sample compartments. The system will be compatible with standard swab- and saliva samples. One of the main objectives in this work is the integration of the microfluidic sampling accessory with the best compact infrared spectrometer on the market (Alpha II), to create a fully automated, cost-effective point of care diagnostics system. Here we embark on an ambitious and enthusiastic collaboration with Bruker Ltd. who will donate significant resources and expertise to all levels of this project, and who will be a key partner for the eventual launch of the finalized tool. A second major objective is to develop modern bioinformatics tools to be applied to absorbance spectra. Once this partnership is established the new technology will be rapidly developed with the following advantages: (1) Completely stand-alone turn-key system, minimizing complexity, time delays and sample management; (2) Direct measurements on primary samples, eliminating reliance on complex lab based techniques using expensive and limited kits; (3) Low-cost spectrometer, disposable microfluidic devices, and an assaying accessory; (4) Highly portable system based on a low-profile system for point of care applications; (5) Fast results are expected to be achieved in 2 to 10 minutes per sample.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
555265-2020
Name nom
Greener, Jesse
Department département
Chimie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Live viral spectroscopy for rapid Covid-19 detection applied directly to clinical biofluids without sample processing_x000d_
_x000d_
Keyword
NSERC
Application summary
We propose a new partnership to advance the core technology for an innovative approach to rapid detection of COVID-19 called "live virus spectroscopy". The initiative brings together experts in virology, microfluidics, mechanical engineering, bioinformatics, and COVID diagnostics with world-leaders in spectroscopic instrument manufactures, Bruker, to advance and rapidly commercialize a new COVID-19 test method. The platform is based on a new patent pending microfluidic technology from Greener and Bégin-Drolet that will automatically meter and concentrate analytes, before obtaining high quality vibrational spectra independently from up to 20 sample compartments. The system will be compatible with standard swab- and saliva samples. One of the main objectives in this work is the integration of the microfluidic sampling accessory with the best compact infrared spectrometer on the market (Alpha II), to create a fully automated, cost-effective point of care diagnostics system. Here we embark on an ambitious and enthusiastic collaboration with Bruker Ltd. who will donate significant resources and expertise to all levels of this project, and who will be a key partner for the eventual launch of the finalized tool. A second major objective is to develop modern bioinformatics tools to be applied to absorbance spectra. Once this partnership is established the new technology will be rapidly developed with the following advantages: (1) Completely stand-alone turn-key system, minimizing complexity, time delays and sample management; (2) Direct measurements on primary samples, eliminating reliance on complex lab based techniques using expensive and limited kits; (3) Low-cost spectrometer, disposable microfluidic devices, and an assaying accessory; (4) Highly portable system based on a low-profile system for point of care applications; (5) Fast results are expected to be achieved in 2 to 10 minutes per sample.